Investigating the Selectivity of Metalloenzyme Inhibitors in the Presence of Competing Metalloproteins.
Ontology highlight
ABSTRACT: Metalloprotein inhibitors (MPi) are an important class of therapeutics for the treatment of a variety of diseases, including hypertension, cancer, and HIV/AIDS. However, despite their clinical success, there is an apprehension that MPi may be less selective than other small-molecule therapeutics and more prone to inhibit off-target metalloenzymes. We examined the issue of MPi specificity by investigating the selectivity of a variety of MPi against a representative panel of metalloenzymes in the presence of competing metalloproteins (metallothionein, myoglobin, carbonic anhydrase, and transferrin). Our findings reveal that a wide variety of MPi do not exhibit a decrease in inhibitory activity in the presence of large excesses of competing metalloproteins, suggesting that the competing prote
SUBMITTER: Chen Y
PROVIDER: S-EPMC4658394 | biostudies-literature | 2015 Oct
REPOSITORIES: biostudies-literature
ACCESS DATA